Basic immunization against TBE in persons over fifty years with FSME-IMMUN Adults

• Conditions: Prophylaxis of TBE in adult persons over fifty years A84.1; A84.1; Central European tick-borne encephalitis

• Registration Number: DRKS00003496
• Lead Sponsor: Baxter Deutschland GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01-25
• Study Completion: 2012-10-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 411

Inclusion Criteria

All patients 50 years and older who receive the basic immunization with FSME-IMMUN Adults can be considered for the target population.
The patients must not have received any TBE vaccination in the past and must not have ever been infected with TBE. They must have given their written consent to participate in this noninterventional study.

Exclusion Criteria

no exclusion criteria

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identify methods for motivating patients for TBE vaccination in practices: Documentation once per site on a separate questionnaire. <br>Collect patients' motivation and indication for TBE vaccination: Documentation once in the CRF. <br>Identify vaccinations with FSME-IMMUN Adults: Documentation in the CRF.<br>Documentation in the CRF whether the antibody concentration is determined after the 2nd vaccination<br>- If performed: Identify antibody concentration<br>- If performed: Identify whether the antibody measurement leads to<br>administration of an additional vaccine dose.<br>- If yes: Documentation of the additional vaccination